Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey.

Mallet P, Mourdi N, Dubus JC, Bavoux F, Boyer-Gervoise MJ, Jean-Pastor MJ, Chalumeau M.

PLoS One. 2011;6(7):e22792. doi: 10.1371/journal.pone.0022792. Epub 2011 Jul 27.

2.

Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.

Duijvestijn YC, Mourdi N, Smucny J, Pons G, Chalumeau M.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003124. doi: 10.1002/14651858.CD003124.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD003124.

PMID:
19160217
3.

Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.

Chalumeau M, Duijvestijn YC.

Cochrane Database Syst Rev. 2013 May 31;(5):CD003124. doi: 10.1002/14651858.CD003124.pub4. Review.

PMID:
23728642
4.

[Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem?].

Chalumeau M, Chéron G, Assathiany R, Moulin F, Bavoux F, Bréart G, Pons G.

Arch Pediatr. 2002 Nov;9(11):1128-36. French.

PMID:
12503503
5.

Perceived adverse drug reactions among non-institutionalized children and adolescents in Germany.

Knopf H, Du Y.

Br J Clin Pharmacol. 2010 Sep;70(3):409-17. doi: 10.1111/j.1365-2125.2010.03713.x.

6.

Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009.

Aldea A, García Sánchez-Colomer M, Fernández Quintana E, García Sáiz M.

Eur J Clin Pharmacol. 2012 Sep;68(9):1329-38. doi: 10.1007/s00228-012-1255-0. Epub 2012 Mar 14.

PMID:
22415248
7.
8.

[Mucolytic drugs: towards a contraindication in infants].

Mourdi N, Dubus JC, Bavoux F, Boyer-Gervoise M, Jean-Pastor MJ, Chalumeau M.

Arch Pediatr. 2010 Jun;17(6):735-6. doi: 10.1016/S0929-693X(10)70084-1. Review. French. No abstract available.

PMID:
20654866
9.

Theory and practice of the use of expectorants reviewed from clinical aspects.

Nagy G.

Ther Hung. 1984;32(1):6-12. Review. No abstract available.

PMID:
6400475
10.

What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?

Kao LW, Kirk MA, Furbee RB, Mehta NH, Skinner JR, Brizendine EJ.

Ann Emerg Med. 2003 Dec;42(6):741-50.

PMID:
14634597
11.

Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.

Fattal-Valevski A, Kesler A, Sela BA, Nitzan-Kaluski D, Rotstein M, Mesterman R, Toledano-Alhadef H, Stolovitch C, Hoffmann C, Globus O, Eshel G.

Pediatrics. 2005 Feb;115(2):e233-8.

PMID:
15687431
12.

Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database.

Moulis G, Sommet A, Sailler L, Lapeyre-Mestre M, Montastruc JL; French Association Of Regional Pharmacovigilance Centers.

Platelets. 2012;23(6):490-4. doi: 10.3109/09537104.2011.633179. Epub 2011 Nov 18.

PMID:
22098130
13.

Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database.

Taugourdeau-Raymond S, Rouby F, Default A, Jean-Pastor MJ; French Network of Pharmacovigilance Centers.

Eur J Clin Pharmacol. 2012 Jul;68(7):1103-7. doi: 10.1007/s00228-012-1232-7. Epub 2012 Feb 16.

PMID:
22349162
14.

Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.

Michenot F, Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc JL; French Network of PharmacoVigilance Centres.

Pharmacoepidemiol Drug Saf. 2006 Oct;15(10):735-40.

PMID:
16924603
15.

[Knowledge creation about adverse drug reactions in the paediatric population].

Aagaard L.

Ugeskr Laeger. 2013 Feb 4;175(6):342-5. Danish.

PMID:
23402239
16.

[Tolerability of Icelandic moss lozenges in upper respiratory tract diseases - multicentric drug monitoring study with 3,143 children].

Hecker M, Völp A.

Forsch Komplementarmed Klass Naturheilkd. 2004 Apr;11(2):76-82. German.

PMID:
15138371
17.
18.
19.

Model systems for the evaluation of mucolytic drugs: acetylcysteine and S-carboxymethylcysteine.

Livingstone CR, Andrews MA, Jenkins SM, Marriott C.

J Pharm Pharmacol. 1990 Feb;42(2):73-8.

PMID:
1972405
20.

Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study.

Rashed AN, Wong IC, Cranswick N, Tomlin S, Rascher W, Neubert A.

Eur J Clin Pharmacol. 2012 May;68(5):801-10. doi: 10.1007/s00228-011-1183-4. Epub 2011 Dec 14.

PMID:
22166934

Supplemental Content

Support Center